In the Fight against Infectious Disease, Social Changes Are the New Medicine - Scientific American
Division of Infectious Diseases and Epidemiology - Penn State College of Medicine
Why Global Health R&D | Global Health Innovative Technology Fund
GHIT Fund RFP 2013-002
Estimating the cost of vaccine development against epidemic infectious diseases: a cost minimisation study - The Lancet Global Health
Research-based pharmaceutical industry 360-degree efforts to fight Neglected Tropical Diseases (NTDs) 2013 - IFPMA
Infectious Diseases, Conflict, and Humanitarian Crises | Center for Global Health Science and Security | Georgetown University
GHIT Fund Announces New Investments: A Total of 790 Million Yen for Product Development of Neglected Tropical Diseases
GHIT Fund secures $20 million pledge from Wellcome | Philanthropy news | PND
GHIT Fund secures $20 million pledge from Wellcome | Philanthropy news | PND
Multi-country collaboration in responding to global infectious disease threats: lessons for Europe from the COVID-19 pandemic - The Lancet Regional Health – Europe
Why Global Health R&D | Global Health Innovative Technology Fund
A new Korean Research Investment for Global Health Technology (RIGHT) Fund to advance innovative neglected-disease technologies | PLOS Neglected Tropical Diseases
GLOBAL HEALTH TECHNOLOGY DISCOVERY AND DEVELOPMENT GHIT Fund Request for Proposals
Hit and lead criteria in drug discovery for infectious diseases of the developing world | Nature Reviews Drug Discovery
GHIT Fund Archives - Asian Scientist Magazine
Malaria Research—What Next? | Science
GHIT Fund Announces New Investments: A Total of 790 Million Yen for Product Development of Neglected Tropical Diseases
Global Health Innovative Technology (GHIT) Fund – Global Health Progress
What Can a Pharmaceutical Company Do to Save People from Infectious Diseases? - An interview with Osamu Kunii, CEO of the GHIT Fund - Our Stories - Daiichi Sankyo
GHIT Fund Brochure — BI BOOP
A New Partner for Global Health Innovative Technology (GHIT) Fund
Investment Opportunities | Global Health Innovative Technology Fund
Joint research identifies hit compounds for the development of a new treatment for malaria Mitsubishi Tanabe Pharma uses its com
